BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12030599)

  • 1. Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
    Straight AM; Patel A; Fenton C; Dinauer C; Tuttle RM; Francis GL
    J Endocrinol Invest; 2002 Apr; 25(4):302-8. PubMed ID: 12030599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.
    Patel A; Jhiang S; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
    Pediatr Res; 2002 Nov; 52(5):737-44. PubMed ID: 12409522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents.
    Patel A; Straight AM; Mann H; Duffy E; Fenton C; Dinauer C; Tuttle RM; Francis GL
    J Endocrinol Invest; 2002 May; 25(5):403-8. PubMed ID: 12035934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid carcinomas from children and adolescents express IGF-I and the IGF-I receptor (IGF-I-R). Cancers with the most intense IGF-I-R expression may be more aggressive.
    Gydee H; O'Neill JT; Patel A; Bauer AJ; Tuttle RM; Francis GL
    Pediatr Res; 2004 Apr; 55(4):709-15. PubMed ID: 14973173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
    Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in benign and malignant thyroid tumors.
    Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
    Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity in benign and malignant human thyroid tissues.
    Cheng AJ; Lin JD; Chang T; Wang TC
    Br J Cancer; 1998 Jun; 77(12):2177-80. PubMed ID: 9649130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma.
    Ramirez R; Hsu D; Patel A; Fenton C; Dinauer C; Tuttle RM; Francis GL
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):635-44. PubMed ID: 11106926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults.
    Fenton C; Patel A; Dinauer C; Robie DK; Tuttle RM; Francis GL
    Thyroid; 2000 Apr; 10(4):349-57. PubMed ID: 10807064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents.
    Patel A; Fenton C; Terrell R; Powers PA; Dinauer C; Tuttle RM; Francis GL
    J Endocrinol Invest; 2002 Sep; 25(8):675-83. PubMed ID: 12240898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents.
    Shah R; Banks K; Patel A; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4391-7. PubMed ID: 12213904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
    Hoelting T; Siperstein AE; Clark OH; Duh QY
    J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
    Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threshold primary tumour sizes for nodal and distant metastases in papillary and follicular thyroid cancers.
    Zaman Mu; Fatima N; Sajjad Z; Akhtar J; Islam N; Masood Q; Ahmed A
    Asian Pac J Cancer Prev; 2012; 13(6):2473-6. PubMed ID: 22938406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients.
    Costello A; Rey-Hipolito C; Patel A; Oakley K; Vasco V; Calabria C; Tuttle RM; Francis GL
    Thyroid; 2005 Feb; 15(2):105-13. PubMed ID: 15753667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
    Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
    Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and telomere length in benign and malignant human thyroid tissues.
    Kammori M; Takubo K; Nakamura K; Furugouri E; Endo H; Kanauchi H; Mimura Y; Kaminishi M
    Cancer Lett; 2000 Oct; 159(2):175-81. PubMed ID: 10996729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.